Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESTIN: Dexmedetomidine vs Sufentanil in TBI
NCT07244822Completed
- Sponsor
- Universitas Jenderal Soedirman
- Start
- Jun 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in traumatic brain injury (TBI) (2 arms), sponsored by Universitas Jenderal Soedirman. Primary endpoint: Cerebral oxygen saturation. Started Jun 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT07244822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07244822.